Advertisement

Survey of how different groups of veterinarians manage the use of neuromuscular blocking agents in anesthetized dogs

Published:March 22, 2018DOI:https://doi.org/10.1016/j.vaa.2018.03.002

      Abstract

      Objective

      To analyze practice habits associated with the use, reversal and monitoring of nondepolarizing neuromuscular blocking agents (NMBAs) in dogs by different groups of veterinarians.

      Study design

      Online anonymous survey to veterinarians.

      Population

      Data from 390 answered surveys.

      Methods

      A questionnaire was sent to e-mail list servers of the American College of Veterinary Anesthesia and Analgesia (ACVAA-list), Sociedad Española de Anestesia y Analgesia Veterinaria (SEEAV-list), Colégio Brasileiro de Anestesiologia Veterinária (Brazilian College of Veterinary Anesthesiology; CBAV-list) and American College of Veterinary Ophthalmologists (ACVO-list) to elicit information regarding use of NMBAs and reversal agents, monitoring techniques, criteria for redosing, reversing and assessing adequacy of recovery of neuromuscular function. Binomial logistic regression was used to test for association between responses and group of veterinarians in selected questions.

      Results

      Veterinarians of the ACVO-list use NMBAs on a higher fraction of their caseload than other groups (all p < 0.0001). Subjective assessment (observation) of spontaneous movement, including spontaneous breathing, is the most common method for assessing neuromuscular function (43% of pooled responses); 18% of participants always reverse NMBAs, whereas 16% never reverse them. Restoration of neuromuscular function is assessed subjectively by 35% of respondents. Residual neuromuscular block is the most common concern regarding the use of NMBAs for all groups of veterinarians. Side effects of reversal agents (anticholinesterases) were of least concern for all groups.

      Conclusions and clinical relevance

      While most veterinarians are concerned about residual neuromuscular block, relatively few steps are implemented to reduce the risks of this complication, such as routine use of quantitative neuromuscular monitoring or routine reversal of NMBAs. These results suggest a limitation in transferring information among groups of veterinarians, or in implementing techniques suggested by scientific research.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Veterinary Anaesthesia and Analgesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ansermino J.M.
        • Sanderson P.M.
        • Bevan J.C.
        • Bevan D.R.
        Acceleromyography improves detection of residual neuromuscular blockade in children.
        Can J Anaesth. 1996; 43: 589-594
        • Antman E.M.
        • Lau J.
        • Kupelnick B.
        • et al.
        A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.
        JAMA. 1992; 268: 240-248
        • Auer U.
        • Mosing M.
        • Moens Y.P.
        The effect of low dose rocuronium on globe position, muscle relaxation and ventilation in dogs: a clinical study.
        Vet Ophthalmol. 2007; 10: 295-298
        • Briganti A.
        • Barsotti G.
        • Portela D.A.
        • et al.
        Effects of rocuronium bromide on globe position and respiratory function in isoflurane-anesthetized dogs: a comparison between three different dosages.
        Vet Ophthalmol. 2015; 18: 89-94
        • Della Rocca G.
        • Iannuccelli F.
        • Pompei L.
        • et al.
        Neuromuscular block in Italy: a survey of current management.
        Minerva Anestesiol. 2012; 78: 767-773
        • Gätke M.R.
        • Viby-Mogensen J.
        • Rosenstock C.
        • et al.
        Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used.
        Acta Anaesthesiol Scand. 2002; 46: 207-213
        • Haynes B.
        • Haines A.
        Barriers and bridges to evidence based clinical practice.
        BMJ. 1998; 317: 273-276
        • Lundstrøm L.H.
        • Møller A.M.
        • Rosenstock C.
        • et al.
        Avoidance of neuromuscular blocking agents may increase the risk of difficult tracheal intubation: a cohort study of 103,812 consecutive adult patients recorded in the Danish Anaesthesia Database.
        Br J Anaesth. 2009; 103: 283-290
        • Madsen M.V.
        • Staehr-Rye A.K.
        • Gätke M.R.
        • Claudius C.
        Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review.
        Acta Anaesthesiol Scand. 2015; 59: 1-16
        • Martin-Flores M.
        • Sakai D.M.
        • Campoy L.
        • Gleed R.D.
        Recovery from neuromuscular block in dogs: restoration of spontaneous ventilation does not exclude residual blockade.
        Vet Anaesth Analg. 2014; 41: 269-277
        • Martin-Flores M.
        • Campoy L.
        • Ludders J.W.
        • et al.
        Comparison between acceleromyography and visual assessment of train-of-four for monitoring neuromuscular blockade in horses undergoing surgery.
        Vet Anaesth Analg. 2008; 35: 220-227
        • McEwin L.
        • Merrick P.M.
        • Bevan D.R.
        Residual neuromuscular blockade after cardiac surgery: pancuronium vs rocuronium.
        Can J Anaesth. 1997; 44: 891-895
        • Murphy G.S.
        • Szokol J.W.
        • Marymont J.H.
        • et al.
        Recovery of neuromuscular function after cardiac surgery: pancuronium versus rocuronium.
        Anesth Analg. 2003; 96: 1301-1307
        • Murphy G.S.
        • Szokol J.W.
        • Marymont J.H.
        • et al.
        Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit.
        Anesth Analg. 2008; 107: 130-137
        • Murphy G.S.
        • Szokol J.W.
        • Marymont J.H.
        • et al.
        Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit.
        Anesthesiology. 2008; 109: 389-398
        • Naguib M.
        • Kopman A.F.
        • Lien C.A.
        • et al.
        A survey of current management of neuromuscular block in the United States and Europe.
        Anesth Analg. 2010; 111: 110-119
        • Nava-Ocampo A.A.
        • Ramirez-Mora J.C.
        • Moyao-Garcia D.
        • et al.
        Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey.
        BMC Anesthesiol. 2002; 2: 2
        • Pandit J.J.
        • Andrade J.
        • Bogod D.G.
        • et al.
        5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors.
        Br J Anaesth. 2014; 113: 549-559
        • Smith A.F.
        • Mort M.
        • Goodwin D.
        • Pope C.
        Making monitoring ‘work’: human-machine interaction and patient safety in anaesthesia.
        Anaesthesia. 2003; 58: 1070-1078
        • Teoh W.H.
        • Ledowski T.
        • Tseng P.S.
        Current trends in neuromuscular blockade, management, and monitoring amongst Singaporean anaesthetists.
        Anesthesiol Res Pract. 2016; 2016: 7284146